Triamcinolone

Generic Name
Triamcinolone
Brand Names
Allernaze, Aristocort, Aristocort R, Juulissa Pharmapak, Kenalog, Kourzeq, Marcaine, Nasacort, Oracort, Oralone, Pediaderm Ta, Triaderm, Trianex, Triderm, Triesence, Triloan Suik, Tritocin, Viaderm Kc, Xipere, Zilretta
Drug Type
Small Molecule
Chemical Formula
C21H27FO6
CAS Number
124-94-7
Unique Ingredient Identifier
1ZK20VI6TY
Background

Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly see...

Indication

肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。

Associated Conditions
Acne, Acne Vulgaris, Acute Gouty Arthritis, Allergic Contact Dermatitis, Allergic Rhinitis (AR), Allergic Skin Reaction, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aphthous Stomatitis, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bullous dermatitis herpetiformis, Chronic Eczema, Chronic Inflammatory Skin Diseases, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Crohn's Disease (CD), Dental Cavity, Dermatitis, Dermatomyositis (DM), Diaper Rash, Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Erythroderma, Fungal Infections, Fungal infectious disorders of the Beard, Fungal skin infection, Gingivitis, Haemorrhoids, Hemangiomas, Hypercalcemia, Inflammation of Mouth, Intertrigo, Itching of the Anus, Itching of the External Genitalia, Itching of the Foot, Itching of the genitals, Itching of the hand, Juvenile Idiopathic Arthritis (JIA), Keloids Scars, Leukemias, Lichen Planus (LP), Lichen simplex chronicus, Lymphoma, Macular Edema, Mycosis Fungoides (MF), Mycotic Eczema, Necrobiosis lipoidica diabeticorum, Neurodermatitis, Nummular Dermatitis, Ocular Inflammation, Ophthalmia, Sympathetic, Oral Erosive Lichen Planus, Otitis Externa, Pemphigus, Pericarditis, Polymyositis, Postherpetic Neuralgia, Primary adrenocortical insufficiency, Proteinuria, Psoriasis Vulgaris (Plaque Psoriasis), Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Purulent Wounds, Pyoderma caused by susceptible bacteria, Regional Enteritis, Rheumatoid Arthritis, Ringworm Folliculitis, Seborrheic Dermatitis, Seborrheic Dermatitis, Eczematous, Secondary Impetiginization, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Skin chapped, Stomatitis, Denture, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Tinea Corporis, Transfusion Reactions, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Urticaria, Uveitis, Wound Infections, Acute Bursitis, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Corticosteroid-responsive dermatoses, Cutaneous candidiasis, Cystic tumour of the ganglia, Exfoliative erythroderma, Granuloma annulare lesions, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Oral infections, Oral lesions, Severe Erythema multiforme, Subacute Dermatitis, Eczematous, Symptomatic Sarcoidosis, Ulceration of the mouth, Ulcerative stomatitis
Associated Therapies
-

Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis

First Posted Date
2008-04-15
Last Posted Date
2017-06-14
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
40
Registration Number
NCT00658736
Locations
🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

A Prospective Study of EUS Guided Celiac Block

First Posted Date
2007-12-31
Last Posted Date
2014-09-05
Lead Sponsor
Indiana University
Target Recruit Count
127
Registration Number
NCT00583271
Locations
🇺🇸

Clarian Health: Indiana University Hospital, Indianapolis, Indiana, United States

Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture

Phase 3
Completed
Conditions
Interventions
First Posted Date
2007-11-29
Last Posted Date
2013-12-13
Lead Sponsor
Sunnybrook Health Sciences Centre
Target Recruit Count
51
Registration Number
NCT00565019
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Division of Plastic Surgery, Toronto, Ontario, Canada

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy

First Posted Date
2007-03-08
Last Posted Date
2016-08-26
Lead Sponsor
Jaeb Center for Health Research
Target Recruit Count
333
Registration Number
NCT00445003
Locations
🇺🇸

University of Illinois at Chicago Medical Center, Chicago, Illinois, United States

🇺🇸

Bay Area Retina Associates, Walnut Creek, California, United States

🇺🇸

Southeast Retina Center, P.C., Augusta, Georgia, United States

and more 51 locations

Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema

Phase 1
Conditions
First Posted Date
2006-12-05
Last Posted Date
2008-05-07
Lead Sponsor
Federal University of São Paulo
Target Recruit Count
50
Registration Number
NCT00407849
Locations
🇧🇷

Vision Institute, Federal University of Sao Paulo, Sao Paulo, SP, Brazil

Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy

Phase 3
Completed
Conditions
First Posted Date
2006-09-08
Last Posted Date
2006-10-12
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Registration Number
NCT00373282
Locations
🇮🇷

Hamid Ahmadieh,MD, Tehran, Iran, Islamic Republic of

Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema

Phase 3
Conditions
First Posted Date
2006-09-01
Last Posted Date
2007-02-22
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
150
Registration Number
NCT00370669
Locations
🇮🇷

Masoud Soheilian, Tehran, Iran, Islamic Republic of

Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion

Phase 2
Completed
Conditions
First Posted Date
2006-08-31
Last Posted Date
2008-06-17
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
30
Registration Number
NCT00370266
Locations
🇮🇷

Alireza Ramezani, MD, Tehran, Iran, Islamic Republic of

A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema

Phase 2
Completed
Conditions
First Posted Date
2006-08-30
Last Posted Date
2007-02-28
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
76
Registration Number
NCT00369863
Locations
🇮🇷

Labbafinejad Medical Center, Tehran, Iran, Islamic Republic of

Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2006-06-27
Last Posted Date
2009-12-07
Lead Sponsor
Sanofi
Target Recruit Count
77
Registration Number
NCT00344942
Locations
🇫🇷

Sanofi-Aventis, Paris, France

© Copyright 2024. All Rights Reserved by MedPath